Hayder Raed Fadhil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hayder Raed Fadhil has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdullahi Ahmad
Department of Pharmaceutical and Medicinal Chemistry, Ahmadu Bello University, Zaria 810107, Nigeria
1 shared publication - Ananya Rahman Shatabdy
Department of Microbiology, Jahangirnagar University, Savar 1342, Bangladesh
1 shared publication - Ayad Mohammed Rasheed Raauf
Al-Farahidi University
1 shared publication - Faleh A Khudhair
College of Pharmacy, Kut University, Kut 52001, Iraq
1 shared publication - Mays Fadhil Mohammed-Kadhum
Mustansiriyah University, Baghdad, Iraq
1 shared publication - Md. Al-Amin
Faculty of Science, Department of Chemistry, Jagannath University, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 14 November 2026
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 5 (4) , 59
Docking-Score Concordance Among Alzheimer’s Disease Kinases Reflects Ligand Properties Rather than Pocket Similarity: A Flavonoid Screen Validated in a Chemically Unrelated Library
Background/Objectives: Multi-target claims in computational studies of Alzheimer’s disease rest on docking scores compared across receptors, although receptor-specific baselines are rarely established. We asked whether such concordance reflects binding-site complementarity or the calculation. Methods: 264 flavonoids were filtered by predicted absorption, distribution, metabolism, excretion and toxicity (ADMET) and prioritized by predicted kinase activity (49 retained); network pharmacology identified eight Alzheimer-associated core targets. Glide extra-precision (XP) docking was validated at each receptor by re-docking the co-crystallized ligand, whose score served as a receptor-specific baseline. ATP pockets were compared structurally, and the analysis was repeated for 122 unrelated compounds. Results: Baselines spanned −2.515 to −10.920 kcal/mol, exceeding the differences between compounds; normalization reordered the campaign completely (Spearman ρ = 0.078). Scores correlated between all kinase pairs (mean r = 0.693) yet showed no detectable relationship with pocket sequence identity (Mantel p = 0.29) or any SiteMap descriptor, whereas free hydroxyl count—the dominant marker of a polarity axis—explained 50–80% of the variance, its removal collapsing the correlation to 0.080. The diverse library reproduced stronger agreement (mean r = 0.776) on one latent axis carrying 81.4% of the variance, again showing no relationship to pocket similarity (p = 0.86). Robinetin ranked first at AKT1 after normalization and stayed in the ATP cleft throughout two independent 100 ns trajectories (Molecular Mechanics/Generalized Born Surface Area, MM-GBSA, −137.2 ± 20.7 kcal/mol), although hydrogen-bond occupancies differed between runs. Conclusions: Concordant docking scores reflect the calculation rather than binding-site complementarity and cannot alone support a multi-target mechanism; receptor normalization and ligand-descriptor deconvolution are minimum requirements.
- 14 November 2026
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 5 (4) , 59
Open AccessDocking-Score Concordance Among Alzheimer’s Disease Kinases Reflects Ligand Properties Rather than Pocket Similarity: A Flavonoid Screen Validated in a Chemically Unrelated Library
Background/Objectives: Multi-target claims in computational studies of Alzheimer’s disease rest on docking scores compared across receptors, although receptor-specific baselines are rarely established. We asked whether such concordance reflects binding-site complementarity or the calculation. Methods: 264 flavonoids were filtered by predicted absorption, distribution, metabolism, excretion and toxicity (ADMET) and prioritized by predicted kinase activity (49 retained); network pharmacology identified eight Alzheimer-associated core targets. Glide extra-precision (XP) docking was validated at each receptor by re-docking the co-crystallized ligand, whose score served as a receptor-specific baseline. ATP pockets were compared structurally, and the analysis was repeated for 122 unrelated compounds. Results: Baselines spanned −2.515 to −10.920 kcal/mol, exceeding the differences between compounds; normalization reordered the campaign completely (Spearman ρ = 0.078). Scores correlated between all kinase pairs (mean r = 0.693) yet showed no detectable relationship with pocket sequence identity (Mantel p = 0.29) or any SiteMap descriptor, whereas free hydroxyl count—the dominant marker of a polarity axis—explained 50–80% of the variance, its removal collapsing the correlation to 0.080. The diverse library reproduced stronger agreement (mean r = 0.776) on one latent axis carrying 81.4% of the variance, again showing no relationship to pocket similarity (p = 0.86). Robinetin ranked first at AKT1 after normalization and stayed in the ATP cleft throughout two independent 100 ns trajectories (Molecular Mechanics/Generalized Born Surface Area, MM-GBSA, −137.2 ± 20.7 kcal/mol), although hydrogen-bond occupancies differed between runs. Conclusions: Concordant docking scores reflect the calculation rather than binding-site complementarity and cannot alone support a multi-target mechanism; receptor normalization and ligand-descriptor deconvolution are minimum requirements.
- Open Access
- 2 November 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 114
Multi-Target In Silico Evaluation of Bioactive Phytocompounds from Irvingia gabonensis Seeds Against Oncogenic Proteins: A Computational Drug Discovery Perspective
Cancer remains a leading cause of mortality in sub-Saharan Africa, with limited access to targeted therapies driving demand for affordable, novel lead compounds. Irvingia gabonensis (Aubry-Lecomte ex O’Rorke) Baill., known as ogbono or African bush mango, is a nutritional staple across West and Central Africa whose seed harbours bioactive phytochemicals. Molecular docking studies were conducted using AutoDock Vina (version 1.2.0) against three oncogenic targets: Bcl-2 (PDB: 6O0K), phosphoinositide 3-kinase gamma (PI3K-gamma; PDB: 1E8X), and the nuclear factor kappa-B p65 subunit (NF-kB p65; PDB: 2RAM). Five phytocompounds, namely ellagic acid, quercetin, kaempferol, lupeol, and beta-sitosterol, were evaluated alongside three reference drugs: venetoclax, idelalisib, and BAY 11-7082. Pharmacokinetic profiling was assessed through Lipinski, Veber, and Ghose drug-likeness filters, and ADMET properties were predicted using computational descriptors. Quercetin exhibited the highest binding affinity among phytocompounds, recording −9.1 kcal/mol against PI3K-gamma and −8.9 kcal/mol against Bcl-2, approaching reference idelalisib (−9.8 kcal/mol). Kaempferol and ellagic acid demonstrated consistent multi-target engagement across all three proteins. Four of five phytocompounds satisfied Lipinski criteria with zero or one violation. ADMET analysis revealed favourable safety profiles relative to reference drugs, with no predicted hERG inhibition or hepatotoxicity across phytocompounds. The phytocompound matrix of I. gabonensis seeds constitutes a computationally validated multi-target oncological scaffold. Quercetin and kaempferol emerge as the most promising phytocompounds for further experimental investigation. This study provides a reproducible computational framework and advances the case for repositioning an African food crop as a natural product lead in cancer drug discovery.
- 2 November 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 114
Open AccessMulti-Target In Silico Evaluation of Bioactive Phytocompounds from Irvingia gabonensis Seeds Against Oncogenic Proteins: A Computational Drug Discovery Perspective
Cancer remains a leading cause of mortality in sub-Saharan Africa, with limited access to targeted therapies driving demand for affordable, novel lead compounds. Irvingia gabonensis (Aubry-Lecomte ex O’Rorke) Baill., known as ogbono or African bush mango, is a nutritional staple across West and Central Africa whose seed harbours bioactive phytochemicals. Molecular docking studies were conducted using AutoDock Vina (version 1.2.0) against three oncogenic targets: Bcl-2 (PDB: 6O0K), phosphoinositide 3-kinase gamma (PI3K-gamma; PDB: 1E8X), and the nuclear factor kappa-B p65 subunit (NF-kB p65; PDB: 2RAM). Five phytocompounds, namely ellagic acid, quercetin, kaempferol, lupeol, and beta-sitosterol, were evaluated alongside three reference drugs: venetoclax, idelalisib, and BAY 11-7082. Pharmacokinetic profiling was assessed through Lipinski, Veber, and Ghose drug-likeness filters, and ADMET properties were predicted using computational descriptors. Quercetin exhibited the highest binding affinity among phytocompounds, recording −9.1 kcal/mol against PI3K-gamma and −8.9 kcal/mol against Bcl-2, approaching reference idelalisib (−9.8 kcal/mol). Kaempferol and ellagic acid demonstrated consistent multi-target engagement across all three proteins. Four of five phytocompounds satisfied Lipinski criteria with zero or one violation. ADMET analysis revealed favourable safety profiles relative to reference drugs, with no predicted hERG inhibition or hepatotoxicity across phytocompounds. The phytocompound matrix of I. gabonensis seeds constitutes a computationally validated multi-target oncological scaffold. Quercetin and kaempferol emerge as the most promising phytocompounds for further experimental investigation. This study provides a reproducible computational framework and advances the case for repositioning an African food crop as a natural product lead in cancer drug discovery.
- Open Access
- 11 September 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-10
Synthesis, characterization, preliminary molecular docking, pharmacological activity, and ADME studies of some new pyrazoline derivatives as anti-breast cancer agents
This work studied the anti-breast cancer activities of pyrazoline-containing benzenesulfonamides (6–10) in vitro and silico. The GOLD suite performed molecular docking on the target human estrogen receptor and the PARPA1 antagonist crystal structure, yielding comparable results using tamoxifen as a reference drug. Researchers tested these compounds (6–10) on two types of breast cancer cells (MCF-7 and MDA-MB-468) in the lab and found an antiproliferative activity that depended on the dose. Compounds 9 demonstrated a high docking score on PARP1 antagonist crystal structure in triple-negative breast cancer with a PLP fitness score of 93.24 and potential antiproliferative activity with an IC50 of 2.79 µM on the MDA-MB-468 cell line. In contrast, compounds 8 and 10 showed promising activity on the MCF-7 cancer cell line with IC50s of 7.4 and 17.96, respectively.
- 11 September 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-10
Open AccessSynthesis, characterization, preliminary molecular docking, pharmacological activity, and ADME studies of some new pyrazoline derivatives as anti-breast cancer agents
This work studied the anti-breast cancer activities of pyrazoline-containing benzenesulfonamides (6–10) in vitro and silico. The GOLD suite performed molecular docking on the target human estrogen receptor and the PARPA1 antagonist crystal structure, yielding comparable results using tamoxifen as a reference drug. Researchers tested these compounds (6–10) on two types of breast cancer cells (MCF-7 and MDA-MB-468) in the lab and found an antiproliferative activity that depended on the dose. Compounds 9 demonstrated a high docking score on PARP1 antagonist crystal structure in triple-negative breast cancer with a PLP fitness score of 93.24 and potential antiproliferative activity with an IC50 of 2.79 µM on the MDA-MB-468 cell line. In contrast, compounds 8 and 10 showed promising activity on the MCF-7 cancer cell line with IC50s of 7.4 and 17.96, respectively.